PK11195-chitosan-graft-polyethylenimine-modified SPION as a mitochondria-targeting gene carrier

References

• Libutti SK. New horizons for cancer gene therapy. Cancer Gene Ther 2014;21:1
   PubMed Web of Science ®Google Scholar
• Liu M, Li ZH, Xu FJ, et al. An oligopeptide ligand-mediated therapeutic gene nanocomplex for liver cancer-targeted therapy. Biomaterials 2012;33:2240–50
   PubMed Web of Science ®Google Scholar
• Dass CR, Choong PF. Non-viral methods for gene transfer towards osteosarcoma therapy. J Drug Target 2007;15:184–9
   PubMed Web of Science ®Google Scholar
• Weissig V, Torchilin VP. Towards mitochondrial gene therapy: Dqasomes as a strategy. J Drug Target 2001;9:1–13
   PubMed Web of Science ®Google Scholar
• Benns JM, Maheshwari A, Furgeson DY, et al. Folate-PEG-folate-graft-polyethylenimine-based gene delivery. J Drug Target 2001;9:123–39
   PubMed Web of Science ®Google Scholar
• Benns JM, Kim SW. Tailoring new gene delivery designs for specific targets. J Drug Target 2000;8:1–12
   PubMed Web of Science ®Google Scholar
• Gao S, Chen J, Xu X, et al. Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting. Int J Pharm 2003;255:57–68
   PubMed Web of Science ®Google Scholar
• Ramamoorth M, Narvekar A. Non viral vectors in gene therapy – an overview. J Clin Diagn Res 2015;9:GE01–6
   PubMed Web of Science ®Google Scholar
• Kane JR, Miska J, Young JS, et al. Sui generis: gene therapy and delivery systems for the treatment of glioblastoma. Neuro Oncol 2015;17:ii24–36
   PubMed Web of Science ®Google Scholar
• Grzeskowiak BF, Sanchez-Antequera Y, Hammerschmid E, et al. Nanomagnetic activation as a way to control the efficacy of nucleic acid delivery. Pharmaceutical Research 2015;32:103–21
   PubMed Web of Science ®Google Scholar
• Al-Deen FN, Ho J, Selomulya C, et al. Superparamagnetic nanoparticles for effective delivery of malaria DNA vaccine. Langmuir 2011;27:3703–12
   PubMed Web of Science ®Google Scholar
• Mok H, Zhang M. Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeutics. Expert Opin Drug Deliv 2013;10:73–87
   PubMed Web of Science ®Google Scholar
• Bhattacharya D, Das M, Mishra D, et al. Folate receptor targeted, carboxymethyl chitosan functionalized iron oxide nanoparticles: a novel ultradispersed nanoconjugates for bimodal imaging. Nanoscale 2011;3:1653–62
   PubMed Web of Science ®Google Scholar
• Bae KH, Ha YJ, Kim C, et al. Pluronic/chitosan shell cross-linked nanocapsules encapsulating magnetic nanoparticles. J Biomater Sci Polym Ed 2008;19:1571–83
   PubMed Web of Science ®Google Scholar
• Jiang HL, Kim YK, Arote R, et al. Chitosan-graft-polyethylenimine as a gene carrier. J Control Release 2007;117:273–80
   PubMed Web of Science ®Google Scholar
• Jiang HL, Kwon JT, Kim YK, et al. Galactosylated chitosan-graft-polyethylenimine as a gene carrier for hepatocyte targeting. Gene Therapy 2007;14:1389–98
   PubMed Web of Science ®Google Scholar
• Zhang BF, Xing L, Cui PF, et al. Mitochondria apoptosis pathway synergistically activated by hierarchical targeted nanoparticles co-delivering siRNA and lonidamine. Biomaterials 2015;61:178–89
   PubMed Web of Science ®Google Scholar
• Henze K, Martin W. Evolutionary biology: essence of mitochondria. Nature 2003;426:127–8
   PubMed Web of Science ®Google Scholar
• McBride HM, Neuspiel M, Wasiak S. Mitochondria: more than just a powerhouse. Curr Biol 2006;16:R551–60
   PubMed Web of Science ®Google Scholar
• Weinberg SE, Chandel NS. Targeting mitochondria metabolism for cancer therapy. Nat Chem Biol 2015;11:9–15
   PubMed Web of Science ®Google Scholar
• Ubah OC, Wallace HM. Cancer therapy: targeting mitochondria and other sub-cellular organelles. Curr Pharm Des 2014;20:201–22
   PubMed Web of Science ®Google Scholar
• Genrikhs EE, Stelmashook EV, Popova OV, et al. Mitochondria-targeted antioxidant SkQT1 decreases trauma-induced neurological deficit in rat and prevents amyloid-beta-induced impairment of long-term potentiation in rat hippocampal slices. J Drug Target 2015;23:347–52
   PubMed Web of Science ®Google Scholar
• Li J, Wang J, Zeng Y. Peripheral benzodiazepine receptor ligand, PK11195 induces mitochondria cytochrome c release and dissipation of mitochondria potential via induction of mitochondria permeability transition. Eur J Pharmacol 2007;560:117–22
   PubMed Web of Science ®Google Scholar
• Veenman L, Papadopoulos V, Gavish M. Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response. Curr Pharm Des 2007;13:2385–405
   PubMed Web of Science ®Google Scholar
• Santidrian AF, Cosialls AM, Coll-Mulet L, et al. The potential anticancer agent PK11195 induces apoptosis irrespective of p53 and ATM status in chronic lymphocytic leukemia cells. Haematologica 2007;92:1631–8
   PubMed Web of Science ®Google Scholar
• Naoi M, Maruyama W, Yi H. Rasagiline prevents apoptosis induced by PK11195, a ligand of the outer membrane translocator protein (18 kDa), in sh-sy5y cells through suppression of cytochrome c release from mitochondria. J Neural Transm 2013;120:1539–51
   PubMed Web of Science ®Google Scholar
• Yoo MK, Park IY, Kim IY, et al. Superparamagnetic iron oxide nanoparticles coated with mannan for macrophage targeting. J Nanosci Nanotechnol 2008;8:5196–202
   PubMed Web of Science ®Google Scholar
• Jiang HL, Xu CX, Kim YK, et al. The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway. Biomaterials 2009;30:5844–52
   PubMed Web of Science ®Google Scholar
• Yamazaki S, Yamabe S. A computational study on addition of grignard reagents to carbonyl compounds. J Org Chem 2002;67:9346–53
   PubMed Web of Science ®Google Scholar
• Li BQ, Jia DC, Zhou Y, et al. In situ hybridization to chitosan/magnetite nanocomposite induced by the magnetic field. J Magnet Mag Mater 2006;306:223–7
   Web of Science ®Google Scholar
• Bhattarai SR, Kim SY, Jang KY, et al. Laboratory formulated magnetic nanoparticles for enhancement of viral gene expression in suspension cell line. J Virol Methods 2008;147:213–18
   PubMed Web of Science ®Google Scholar
• Mulens-Arias V, Rojas JM, Perez-Yague S, et al. Polyethylenimine-coated SPIONs trigger macrophage activation through TLR-4 signaling and ROS production and modulate podosome dynamics. Biomaterials 2015;52:494–506
   PubMed Web of Science ®Google Scholar
• Lee CM, Jeong HJ, Kim SL, et al. SPION-loaded chitosan-linoleic acid nanoparticles to target hepatocytes. Int J Pharm 2009;371:163–9
   PubMed Web of Science ®Google Scholar
• Yuan JJ, Armes SP, Takabayashi Y, et al. Synthesis of biocompatible poly[2-(methacryloyloxy)ethyl phosphorylcholine]-coated magnetite nanoparticles. Langmuir 2006;22:10989–93
   PubMed Web of Science ®Google Scholar
• Longmire M, Choyke PL, Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond) 2008;3:703–17
   PubMed Web of Science ®Google Scholar
• Park MR, Han KO, Han IK, et al. Degradable polyethylenimine-alt-poly(ethylene glycol) copolymers as novel gene carriers. J Control Release 2005;105:367–80
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim YK, Arash MT, et al. Galactosylation of chitosan-graft-spermine as a gene carrier for hepatocyte targeting in vitro and in vivo. J Nanosci Nanotechnol 2012;12:5178–84
   PubMed Web of Science ®Google Scholar
• Greish K. Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. Methods Mol Biol 2010;624:25–37
   PubMedGoogle Scholar
• Kievit FM, Zhang M. Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers. Adv Mater 2011;23:H217–47
   PubMed Web of Science ®Google Scholar
• Ashwell G, Morell AG. The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol Relat Areas Mol Biol 1974;41:99–128
   PubMedGoogle Scholar
• Laurent S, Saei AA, Behzadi S, et al. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges. Expert Opin Drug Deliv 2014;11:1449–70
   PubMed Web of Science ®Google Scholar
• Buerli T, Pellegrino C, Baer K, et al. Efficient transfection of DNA or shRNA vectors into neurons using magnetofection. Nat Protoc 2007;2:3090–101
   PubMed Web of Science ®Google Scholar
• Mykhaylyk O, Antequera YS, Vlaskou D, et al. Generation of magnetic nonviral gene transfer agents and magnetofection in vitro. Nat Protoc 2007;2:2391–411
   PubMed Web of Science ®Google Scholar
• Pickard M, Chari D. Enhancement of magnetic nanoparticle-mediated gene transfer to astrocytes by ‘magnetofection': effects of static and oscillating fields. Nanomedicine (Lond) 2010;5:217–32
   PubMed Web of Science ®Google Scholar
• Ma YJ, Zhang ZJ, Wang XL, et al. Insights into the mechanism of magnetofection using MNPs-PEI/pDNA/free PEI magnetofectins. Int J Pharm 2011;419:247–54
   PubMed Web of Science ®Google Scholar
• Sato T, Ishii T, Okahata Y. In vitro gene delivery mediated by chitosan. Effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials 2001;22:2075–80
   PubMed Web of Science ®Google Scholar
• Babu A, Wang Q, Muralidharan R, et al. Chitosan coated polylactic acid nanoparticle-mediated combinatorial delivery of cisplatin and siRNA/plasmid DNA chemosensitizes cisplatin-resistant human ovarian cancer cells. Mol Pharm 2014;11:2720–33
   PubMed Web of Science ®Google Scholar
• Yamagata H, Shimizu S, Nishida Y, et al. Requirement of voltage-dependent anion channel 2 for pro-apoptotic activity of Bax. Oncogene 2009;28:3563–72
   PubMed Web of Science ®Google Scholar
• Zhang L, Xing D, Chen M. Bim(l) displacing Bcl-x(l) promotes Bax translocation during TNFalpha-induced apoptosis. Apoptosis 2008;13:950–8
   PubMed Web of Science ®Google Scholar
• Barksdale KA, Bijur GN. The basal flux of Akt in the mitochondria is mediated by heat shock protein 90. J Neurochem 2009;108:1289–99
   PubMed Web of Science ®Google Scholar
• Havasi A, Li Z, Wang Z, et al. Hsp27 inhibits Bax activation and apoptosis via a phosphatidylinositol 3-kinase-dependent mechanism. J Biol Chem 2008;283:12305–13
   PubMed Web of Science ®Google Scholar